Clinical Trial Update: Study of Ataluren (PTC124™) in Cystic Fibrosis [Phase 3]

View source ↗

Summary

Phase 3 trial update for ataluren (PTC124) in cystic fibrosis completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• ataluren (PTC124™) (ataluren)

Snippet

Sponsor: PTC Therapeutics | Conditions: Cystic Fibrosis | Phase 3 | Status: COMPLETED | Results posted: 2020-05-14